{"id":"NCT01821391","sponsor":"Galderma R&D","briefTitle":"Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses","officialTitle":"Multi-centre, Randomized, Investigator-blind, Intra-individual Active and Vehicle-controlled Study, Comparing Metvix Natural Daylight Photodynamic Therapy Versus Metvix Conventional Photodynamic Therapy in Subjects With Actinic Keratosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2014-01","completion":"2014-03","firstPosted":"2013-04-01","resultsPosted":"2020-12-10","lastUpdate":"2021-02-18"},"enrollment":131,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratoses"],"interventions":[{"type":"DRUG","name":"NDL-PDT","otherNames":["Metvix NDL-PDT"]},{"type":"DRUG","name":"c-PDT","otherNames":["Metvix c-PDT"]},{"type":"DRUG","name":"placebo c-PDT","otherNames":["Metvix placebo c-PDT"]}],"arms":[{"label":"NDL-PDT/c-PDT","type":"EXPERIMENTAL"},{"label":"NDL-PDT/placebo c-PDT","type":"EXPERIMENTAL"}],"summary":"This study was to be conducted as a multi-centre, randomized, investigator-blinded, active and vehicle-controlled, intra-individual (split-face/scalp) non-inferiority (regarding efficacy) and superiority (regarding pain) study.\n\nThe primary purpose of this study is to demonstrate the non-inferiority of NDL-PDT compared to c-PDT in terms of lesion complete response rate.","primaryOutcome":{"measure":"Percentage (%) Change From Baseline in Total Lesion Complete Response at Week 12 in Group 1","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Group I: Metvix NDL-PDT","deltaMin":68.4,"sd":27.7},{"arm":"Group I: Metvix c-PDT","deltaMin":71.5,"sd":27.6}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.2665"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":18,"countries":["France","Germany","Netherlands","Spain","Sweden"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":131},"commonTop":["Erythema","Pruritus","Scab","Skin burning sensation","Pain of skin"]}}